Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02879695 |
|---|---|
| Brief Title: | Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia |
| First Submitted : | August 23, 2016 |
| First Submitted that Met QC Criteria : | August 23, 2016 |
| First Posted : | August 26, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | February 6, 2024 |
| Last Update Posted : | February 7, 2024 |